Allspring Global Investments Holdings, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023
BUY
$0.89 - $2.52 $2,738 - $7,754
3,077 Added 99.42%
6,172 $5,000
Q4 2022

Jan 23, 2023
SELL
$1.02 - $7.48 $69 - $508
-68 Reduced 2.15%
3,095 $0
Q3 2022

Oct 26, 2022
BUY
$6.04 - $9.66 $19,104 - $30,554
3,163 New
3,163 $23,000
Q2 2022

Jul 25, 2022
SELL
$4.99 - $8.96 $60,748 - $109,079
-12,174 Closed
0 $0
Q1 2022

May 02, 2022
SELL
$3.84 - $9.74 $7,031 - $17,833
-1,831 Reduced 13.07%
12,174 $101,000
Q4 2021

Jan 28, 2022
BUY
$5.12 - $8.19 $71,705 - $114,700
14,005 New
14,005 $72,000

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $418M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email